Deep TMS therapy is effective*, safe and generally well-tolerated* for people with these common brain disorders. The U.S. Food and Drug Administration (FDA) cleared BrainsWay’s™ Deep TMS device for the treatment of depression and OCD (De Novo) in patients who failed to respond to antidepressant medications. The treatment has been demonstrated to be effective in several clinical trials.*

The therapy is not painful or disruptive, does not cause systemic side effects*, and does not require hospitalization or anesthesia.

Treatment involves sitting comfortably in a chair and wearing a helmet containing a patented H-coil for 20-minutes. The coil stimulates the brain by creating a temporary magnetic field.

Deep TMS has been tested in over 60 clinical trials worldwide. It can even help people who have not responded well to medications, or to a combination of psychotherapy and medication.

The treatment platform is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas.

The treatment features unique, patented coils that are fitted into a helmet, which is secured snugly to the patient’s head during the treatment.

BrainsWay’s therapy has been utilized in over 60 clinical trials worldwide. In the U.S., the Company’s device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD).

GREATER ACTIVATION

The electric field induced by the coils stimulate a larger volume of gray matter in the prefrontal cortex (PFC) than do figure-8 coils.

SHORTEST CLINICALLY PROVEN TREATMENTS

Treatment sessions last just 20 minutes, saving you time!

RELIABLE TARGETING

The deeper and broader electric field induced by the H1-coil is much more likely to stimulate relevant prefrontal depression targets consistently.